Cargando…
Need for vigilance monitoring regarding neurological disorders post-COVID vaccination
Autores principales: | Thangaraju, Pugazhenthan, Mannava, Anjali S., Neelambaran, Krishnapriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521825/ https://www.ncbi.nlm.nih.gov/pubmed/37767444 http://dx.doi.org/10.4103/jfmpc.jfmpc_45_23 |
Ejemplares similares
-
Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022) -
Gestational diabetes: Unfolded area still a concern
por: Velmurugan, Hemasri, et al.
Publicado: (2023) -
Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023) -
Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020) -
Vigilance in selection of low-dose versus high-dose steroids in COVID-19
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)